Talphera (TLPH)

• Market cap: $62.5M
• 1 day: 1.52%
• 5 days: 3.88%
• 1 month: 16.52%
• 3 months: 209.83%
• 6 months: 162.8%
• Year to date: 127.08%
• 1 year: 97.12%
• 5 years: -95.68%
• 10 years: -98.72%
• Sector: Healthcare
• Industry: Drug Manufacturers - Specialty & Generic

About: Talphera Inc. is a pharmaceutical company focused on the development and commercialization of therapies for use in medically supervised settings. The Company's nafamostat product candidates include Niyad and LTX-608. Its portfolio consists of nafamostat product candidates and pre-filled syringe product candidates.

Employees: 13